glp 1 agonist peptide GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Frontiers | Glucagon-like peptide-1 receptor
Description
doi: 10.1016/j.cld.2017.08.002

This foundational step helps identify any potential contraindications before a prescription is even considered

Methods FLOW is a randomised, double-blind, parallel-group, multinational, phase 3b trial

Patience helps

GLP-1 Drug Shortages and Compounding July 2024 IPD has released a new podcast episode, GLP-1 Drug Shortages and Compounding," where Alyssa Guest, PharmD, discusses the glucagon-like peptide-1 (GLP-1) drugs and how interest in weight loss, viral social media posts, celebrity endorsements, illegitimate compounding, and drug shortages have all impacted access to GLP-1s

The detection limit was 1.7 micrograms per liter, and every single sample came back below that threshold
